Will the 2026 rise of "phage therapy" finally provide a permanent solution to the superbug crisis?
The year 2026 has introduced a major turning point in the antimicrobial therapeutics market as bacteriophage therapy moves from experimental trials into mainstream clinical use. For decades, the rise of multidrug-resistant bacteria has threatened to render traditional antibiotics useless, but today’s "designer phages" are changing the game. These are viruses engineered to target and...
0 Commentaires 0 Parts 28 Vue 0 Aperçu